Global Bacillus Coagulans Market

Bacillus Coagulans Market Size, Share, Growth Analysis, By Type(Type 1, Type 2, Type 3), By Application(Food, Beverage, Bakery Products, Dairy Products), By Region - Industry Forecast 2024-2031


Report ID: SQSG30C2029 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 70 | Figures: 76

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Bacillus Coagulans Market size was valued at USD 85 million in 2019 and is poised to grow from USD 91.835 million in 2023 to USD 148.16 million by 2031, growing at a CAGR of 8.1% in the forecast period (2024-2031).

The market is consolidated in nature. The prominent players operating in the market are constantly adopting various growth strategies in order to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D in order to supply industries with the most efficient and cost-effective solutions. 'Sabinsa Corporation', 'Ganeden Biotech', 'Lallemand Inc.', 'Nebraska Cultures Inc.', 'UAS Laboratories LLC', 'Unique Biotech Limited', 'Syngen Biotech', 'Synbiotics Limited', 'NutraScience Labs', 'Bioriginal Food & Science Corp.', 'Qingdao NN Bio-tech Co., Ltd.', 'Biovation Labs Inc.', 'Biosearch Life', 'Pure Encapsulations', 'ADM Protexin Limited', 'Bactolac Pharmaceutical, Inc.', 'Nutraceutix, Inc.', 'Thorne Research Inc.', 'Vitamer Labs Inc.', 'Nutralliance Inc.', 'In June 2020, the Mariani Packing Company, a U.S. food products provider, introduced its probiotics products in single use packets with two fruit flavors. The product is a weekly 7-day supply carton that contains probiotic bacillus coagulans. The United States has designated the brand, GanedenBC30, as safe (GRAS). FDA, certified Halal, Kosher, and gluten-free. The company claims that the fiber found in the dried fruits used in its products might be used as a fuel source for B. utilized coagulans Such product introductions support the market potential of probiotic cultures that are active in improving gut health, such as Bacillus coagulans.'

Due to the enormous advantages offered in treating acne and skin issues, the market for Bacillus coagulans is experiencing rising demand in the cosmetics sector. Cosmetics manufacturers are introducing new formulations with Bacillus coagulans for anti-aging properties. Face masks, lotions, scrubs, gels, creams, and cleansers are some of these goods. Manufacturers of cosmetic products are also concentrating on creating cosmeceutical components, such as bacillus coagulans, for use in a variety of cosmetic products, such as cream, lotion, powder, and others. Atopic dermatitis and eczema symptoms are being treated and managed with increasing frequency using Bacillus coagulans. Its inclusion in cosmetic goods like moisturizing lotion and anti-acne face wash is also on the rise. Bacillus coagulans is a biologically active ingredient that protects the skin, and it is frequently used in personal care products.

With new dairy-free probiotic foods entering the market each year, health and wellness continue to be at the forefront of new product development initiatives. Due to the growing vegan and vegetarian population, the need for low milk cholesterol, an increase in milk protein allergies, and an increase in lactose intolerance, there has been a surge in the demand for non-dairy probiotics. The majority of dairy-free food items now commonly contain the ingredient Bacillus coagulans as their principal component. Bacillus coagulans is mostly added to functional food products and dairy-free probiotic supplements because it has been deemed safe by the FDA and EFSA. The demand for heat-treated food products is rising as a result of the high stability of bacillus coagulans during processing and heating. Due to their low cost and availability as an alternative to other dangerous chemical sources, the majority of goods used in the food business that can be manufactured by Bacillus coagulans are becoming more and more popular.

In 2021, Asia-Pacific is expected to have the biggest market share of 42.0%. The region is also projected to be the fastest growing with a CAGR of over the forecast period. This can be attributed to rising healthcare spending by the populace in the region. Given that these countries are the biggest consumers of functional foods and beverages, the growing economies of ASEAN, China, and India are anticipated to be the largest markets for bacillus coagulans. Additionally, one of the key reasons promoting market expansion in these economies is the rising senior population. Further, the North American region is also projected to hold one of the most substantial share in the market attributing to the presence of major players operating in the market in the region.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Bacillus Coagulans Market

Report ID: SQSG30C2029

$5,300
BUY NOW GET FREE SAMPLE